www.mmm-online.com
Open in
urlscan Pro
2606:4700::6812:956
Public Scan
Submitted URL: https://app.info.mmm-online.com/e/er?s=2175572&lid=8766&elqTrackId=99BB8E9DA7871283AF9724FEEC924972&elq=ea0466c8d21540aa9854a169...
Effective URL: https://www.mmm-online.com/home/podcasts/mmm-intern-molly-huth-says-goodbye-podcast/?utm_source=email&utm_medium=email&utm_...
Submission: On August 08 via manual from IN — Scanned from DE
Effective URL: https://www.mmm-online.com/home/podcasts/mmm-intern-molly-huth-says-goodbye-podcast/?utm_source=email&utm_medium=email&utm_...
Submission: On August 08 via manual from IN — Scanned from DE
Form analysis 3 forms found in the DOM
GET https://www.mmm-online.com/
<form role="search" method="get" id="searchform" class="searchform" action="https://www.mmm-online.com/">
<div>
<label class="screen-reader-text" for="s">Search for:</label>
<input type="text" value="" name="s" id="s">
<input type="submit" id="searchsubmit" value="Search">
</div>
</form><form class="HMIRegistration__form" novalidate="">
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="email" id="root_email" label="email" placeholder="*E-mail Address" value=""></div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="password" id="root_password" label="password" placeholder="*Password" value=""></div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__checkbox cbxmmm login_detect"><span class="cbxmmm"><input type="checkbox" id="cbx" class=""><label for="cbx" class="mmm-check "><svg width="18px" height="18px" viewBox="0 0 18 18">
<path d="M1,9 L1,3.5 C1,2 2,1 3.5,1 L14.5,1 C16,1 17,2 17,3.5 L17,14.5 C17,16 16,17 14.5,17 L3.5,17 C2,17 1,16 1,14.5 L1,9 Z"></path>
<polyline points="1 9 7 14 15 4"></polyline>
</svg></label></span><span class="HMIRegistration__text native ">Keep me signed in</span></div>
</div>
</div><button class="HMIRegistration__submit" type="submit">Log in</button>
</form><form class="HMIRegistration__form" novalidate="">
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__form-control HMIRegistration__input"><input class="form-control" type="email" id="root_subscriber_email" label="email" placeholder="*E-mail Address" value=""></div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col6">
<div class="HMIRegistration__form-control HMIRegistration__input"><input class="form-control" id="root_subscriber_firstName" label="firstName" placeholder="*First name" type="text" value=""></div>
</div>
<div class="HMIRegistration__column u-col6">
<div class="HMIRegistration__form-control HMIRegistration__input"><input class="form-control" id="root_subscriber_lastName" label="lastName" placeholder="*Last name" type="text" value=""></div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__form-control HMIRegistration__input"><input class="form-control" type="password" id="root_registerPassword_password" label="password" placeholder="*Password" value=""></div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__form-control HMIRegistration__input"><input class="form-control" id="root_business_company" label="company" placeholder="*Company Name" type="text" value=""></div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col6">
<div class="HMIRegistration__form-control"><select class="HMIRegistration__select">
<option value="">Job Title*</option>
<option value="181">Corporate Management (C-level, President, etc.)</option>
<option value="182">Marketing/Advertising Executive</option>
<option value="183">Product/Brand/Therapeutic Executive (SVP, VP, Director, Manager, etc.)</option>
<option value="184">Media</option>
<option value="185">Creative/Design</option>
<option value="186">Public Relations/Communications</option>
<option value="187">Sales Management</option>
<option value="188">Market Research</option>
<option value="189">CME</option>
<option value="205">Medical Director</option>
<option value="206">Medical/Scientific Affairs</option>
<option value="190">Managed Care</option>
<option value="191">R&D</option>
<option value="192">Regulatory Affairs</option>
<option value="193">Technology</option>
<option value="207">Finance</option>
<option value="194">Operations</option>
<option value="195">Consulting</option>
<option value="208">Educator/Student/Intern</option>
<option value="196">Other</option>
</select>
<div class="HMIRegistration__select--down-caret"><svg width="14 " height="12" class="widget-svg">
<polygon class="down-caret" points="7 12, 14 0, 0 0"></polygon>
</svg></div>
</div>
</div>
<div class="HMIRegistration__column u-col6">
<div class="HMIRegistration__form-control"><select class="HMIRegistration__select">
<option value="">Title Level*</option>
<option value="197">C-Level</option>
<option value="198">VP/SVP/EVP</option>
<option value="199">Director</option>
<option value="200">Manager</option>
<option value="201">Non-Manager</option>
<option value="202">Other</option>
</select>
<div class="HMIRegistration__select--down-caret"><svg width="14 " height="12" class="widget-svg">
<polygon class="down-caret" points="7 12, 14 0, 0 0"></polygon>
</svg></div>
</div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col6">
<div class="HMIRegistration__form-control"><select class="HMIRegistration__select">
<option value="">Industry*</option>
<option value="163">Healthcare Manufacturer - Other</option>
<option value="164">Healthcare Manufacturer - Pharmaceutical</option>
<option value="165">Healthcare Manufacturer - Biotechnology</option>
<option value="166">Healthcare Manufacturer - Device/Diagnostics</option>
<option value="167">Advertising/Marketing/Communications</option>
<option value="168">Media Company</option>
<option value="169">Creative/Design Firm</option>
<option value="170">Market Research Firm</option>
<option value="171">Accredited CME/Education</option>
<option value="172">Healthcare Consulting Company (does not incl. independent consultants)</option>
<option value="173">Technology</option>
<option value="174">Payor/PBM/Insurer</option>
<option value="175">Hospital/Health System/Medical Care</option>
<option value="176">Non-Profit/Association/Government Agency</option>
<option value="203">Retail/Wholesale/Distributor</option>
<option value="204">Private Equity/Finance/Investor</option>
<option value="177">Business Services</option>
<option value="178">Independent Consultant/Freelancer</option>
<option value="180">Other</option>
</select>
<div class="HMIRegistration__select--down-caret"><svg width="14 " height="12" class="widget-svg">
<polygon class="down-caret" points="7 12, 14 0, 0 0"></polygon>
</svg></div>
</div>
</div>
<div class="HMIRegistration__column u-col6">
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__form-control">
<div id="cntry" class="HMIRegistration__select"><select id="*Country" class="HMIRegistration__select">
<option value="">*Country</option>
<option value="US">United States</option>
</select>
<div class="HMIRegistration__select--down-caret"><svg width="14 " height="12" class="widget-svg">
<polygon class="down-caret" points="7 12, 14 0, 0 0"></polygon>
</svg></div>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<h4 class="HMIRegistration__sub-title">Sign up for our email updates.</h4>
<div class="HMIRegistration__form-control--checkbox mmmCheckbxs">
<div class="HMIRegistration__checkbox cbxmmm"><span class="cbxmmm"><input type="checkbox" id="cbx" class="u-active" checked=""><label for="cbx" class="mmm-check "><svg width="18px" height="18px" viewBox="0 0 18 18">
<path d="M1,9 L1,3.5 C1,2 2,1 3.5,1 L14.5,1 C16,1 17,2 17,3.5 L17,14.5 C17,16 16,17 14.5,17 L3.5,17 C2,17 1,16 1,14.5 L1,9 Z"></path>
<polyline points="1 9 7 14 15 4"></polyline>
</svg></label></span><span class="HMIRegistration__text nwscheck u-active">The Splash from MM+M</span></div>
</div>
<div class="HMIRegistration__form-control--checkbox mmmCheckbxs">
<div class="HMIRegistration__checkbox cbxmmm"><span class="cbxmmm"><input type="checkbox" id="cbx" class="u-active" checked=""><label for="cbx" class="mmm-check "><svg width="18px" height="18px" viewBox="0 0 18 18">
<path d="M1,9 L1,3.5 C1,2 2,1 3.5,1 L14.5,1 C16,1 17,2 17,3.5 L17,14.5 C17,16 16,17 14.5,17 L3.5,17 C2,17 1,16 1,14.5 L1,9 Z"></path>
<polyline points="1 9 7 14 15 4"></polyline>
</svg></label></span><span class="HMIRegistration__text nwscheck u-active">MM+M Weekly Digest</span></div>
</div>
<div class="HMIRegistration__form-control--checkbox mmmCheckbxs">
<div class="HMIRegistration__checkbox cbxmmm"><span class="cbxmmm"><input type="checkbox" id="cbx" class="u-active" checked=""><label for="cbx" class="mmm-check "><svg width="18px" height="18px" viewBox="0 0 18 18">
<path d="M1,9 L1,3.5 C1,2 2,1 3.5,1 L14.5,1 C16,1 17,2 17,3.5 L17,14.5 C17,16 16,17 14.5,17 L3.5,17 C2,17 1,16 1,14.5 L1,9 Z"></path>
<polyline points="1 9 7 14 15 4"></polyline>
</svg></label></span><span class="HMIRegistration__text nwscheck u-active">MM+M AM, PM and Weekender</span></div>
</div>
</div>
</div>
<div class="HMIRegistration__row HMIRegistration__opt-in-email">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__checkbox cbxmmm "><span class="cbxmmm"><input type="checkbox" id="cbx" class=""><label for="cbx" class="mmm-check "><svg width="18px" height="18px" viewBox="0 0 18 18">
<path d="M1,9 L1,3.5 C1,2 2,1 3.5,1 L14.5,1 C16,1 17,2 17,3.5 L17,14.5 C17,16 16,17 14.5,17 L3.5,17 C2,17 1,16 1,14.5 L1,9 Z"></path>
<polyline points="1 9 7 14 15 4"></polyline>
</svg></label></span><span class="HMIRegistration__text native ">I would like to receive relevant information via email from MM+M.</span></div>
</div>
</div><input type="hidden" id="root_sendEmailConfirmation" value="true"><button class="HMIRegistration__submit" type="submit">Register</button>
</form>Text Content
HAYMARKET MARKETING COMMUNICATIONS:
* Campaign US
* MM+M
* PRWeek
*
Log In | Register
Search for:
* News
* Agencies
* Five Things to Know
* Data/Analytics
* Campaigns
* Pharma
* Podcasts
* Policy
* Media
* Technology
* People Moves
* The Wire
* In-Depth
* MM+M Best Places to Work 2023
* Career and Salary Survey 2023
* Healthcare Marketers Trend Report
* Events
* MM+M Health Marketing Influencer 25
* Pinnacle Awards
* MM+M 40 Under 40 2024
* MM+M Media Summit
* MM+M Transform
* Women of Distinction
* MM+M Awards
* Webcasts
* Conference + Events Coverage
* Agency 100
* MM+M 2024 Agency 100
* MM+M Agency Showcase 2024
* MM+M 2023 Agency 100
* MM+M 2023 Agency Showcase
* MM+M 2022 Agency Showcase
* MM+M 2021 Agency Showcase
* MM+M 2020 Agency Showcase
* Resources
* Places to Be
* The MM+M Podcast
* eBooks
* Past Issues
* Game Changers 2023
* Career and Salary Survey Premium Edition
* Whitepapers
* Partner Content
* Swoop Partner Channel
Read the latest issue
HAYMARKET MARKETING COMMUNICATIONS:
* Campaign US
* MM+M
* PRWeek
*
QUICK LINKS
* Agency
* People
* Campaigns
* Pharma
* Podcasts
* Reports + Surveys
* Events
Podcasts
MM+M SUMMER INTERN MOLLY HUTH, ‘A NATURAL BEHIND THE MIC,’ SAYS GOODBYE
MM+M’s summer intern, Molly Huth, says goodbye. Plus, our Trends segment touches
on Tim Walz’s healthcare policy record and revelations around Lykos
Therapeutics’ MDMA trials.
MM+M Staff
August 8, 2024
9:34 am
* Share on Facebook
* Share on Twitter
* Share on LinkedIn
* Share on Reddit
* Share by Email
* Print
As summer intern Molly Huth’s rotation at MM+M draws to a close, she sits for an
exit interview with Jack O’Brien and Marc Iskowitz.
Plus, our Trends segment touches on Democratic presidential running mate Tim
Walz’s healthcare policy record and new revelations around Lykos Therapeutics’
MDMA clinical trials.
Music by Sixième Son
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical
marketing, subscribe here.
Note: The MM+M Podcast uses speech-recognition software to generate transcripts,
which may contain errors. Please use the transcript as a tool but check the
corresponding audio before quoting the podcast.
Read the full episode transcript here
Hey, it’s Marc This week we bid farewell to a member of MM+M’s editorial team –
summer intern Molly Huth. Molly came to MM+M in June as a third-year English lit
and human rights studies student at University of Dayton. And since then, she’s
made a solid contribution to the new desk, compiling our “5 Things for Pharma
Marketers to Know” daily update and reporting on everything from pharma
corporate earnings to the health-oriented storylines of Olympic athletes like
Suni Lee. Also impressive is how she’s added her voice to the weekly podcast,
winning us over with her easy going demeanor and ability to discuss current
events through a health-marketing lens. But she’ll face one more test: an exit
interview with her editorial teammates on this week’s show. And for our weekly
Trend segment, we’ll tackle Kamala Harris’ choice of Minnesota governor Tim Walz
as running mate and what we know about his healthcare policy history, as well as
new revelations regarding Lykos Therapeutics’ negative but interesting
psychedelic AdCom discussion for its MDMA-assisted therapy. Awesome. Well, Molly
I’m going to start off with a fairly easy question because I have a number of
them in front of me. But let’s just go with how are you doing? I’m great. Yeah
having a good day, you know got the intern presentation this morning well and
Yeah, I’m glad to be here. So talk to us a little bit about that before we get
into your entire internship experience. I know this started from when you joined
us to where you are right now. What was this project? Yeah, so they pitched it
to us day one. So it was basically our entire group. I think they’re like 20 of
us about we were up into four different subgroups and we are tasked with the
mission of just making a Psychiatry advisor award ceremony. So I was in the
content group. So I was just coming up with Awards and kind of key opinion
leaders doing some internet stocking on the big names in the industry. And yeah,
we compiled it all together today. It was really great to see it all come
together after you know how eight weeks of working on it and emailing about it
and media about it. Were you nervous? I was really nervous like even when I got
up there I was like, oh I can’t breathe but it went well, that’s all. Yes. Let’s
start with just kind of a Cap on your experience you you were working on that
internship project you were working for us in terms of writing stuff for the
website interviews. You were also doing work with the medical advertising Hall
of Fame talk to us a little bit about the stuff with medical advertising Hall of
Fame. I know you had alluded to it in earlier episodes, but now you’re in your
final week and handing it off Yeah. So basically they’re looking to make another
addition just an updated version of the last I think he’s going back to 2010 of
just kind of the best of the best and so I went through all the mmm Wars we had
to do some digging some going back to old paper copies from like 2010. Thanks to
Kevin shout out Kevin. But yeah, so he basically just compiled they they chose a
couple of different categories that they wanted to focus on and we listed, you
know, the company name the people who made the whatever it may have been and
then just either the product launch or whatever it was that they’re being on
for. Very cool. I’m curious what you’ve learned. This is an industry that
admittedly I didn’t know a ton about when I first came over here and I’ve leaned
on Mark considerably because he has so much industry experience and knowledge
for you what has been some of the biggest learnings from you know, is it been
watching TV differently where you’re like, oh that’s a pharmaceutical ad or is
it something about the way they’re putting together these campaigns what really
sticks out to you? Yeah, I think All of that. I mean when I’m watching TV, I’m
like, oh my God, I know that company. Um, or I’ll be like, oh that drug. I just
wrote about that. Um, but yeah, I came into it really only knowing the extent of
my knowledge was from watching dope sick and so not a great impression of the
Pharma industry, but you know, I’ve learned a ton and it’s really it’s made me
very optimistic about just like I’m anxious person. I’m always like what if I’m
I’m always a hypochondriac it’s nice to know that people are working towards
some really amazing things. And yeah, I’ve just I never really I always knew it
was a massive industry, but I didn’t understand especially until I was doing the
financial reports and stuff like that for the second quarter of this year. Just
how much money is in these companies. I was even telling my dad and he was like
wait that’s their market cap as like, yeah, it’s not crazy. But um, it was
really cool and I I learned a lot and even just with the Olympics too. I didn’t
really Is you know the kind of international stage that companies had like Eli
Lilly and all of them? Yeah. It was really cool. Awesome Mark. I want to bring
you in here in case you have any sort of questions. I have a few other ones
written down but want to bring you in I appreciate that. Yeah. Yeah. I was
really impressed. You know that you’ve already in your short time here already
amassed five pages and the mmm Archive of your stories, you know, as you said
everything from the financial learning to the Olympic coverage, but you also did
some you know Straight Ahead marketing coverage and you know, this is a B2B, you
know where you’re not reporting for, you know, a mainstream, you know, you’re
kind of looking at it through a particular lens, but I wanted to you know asked
you how you were able to kind of, you know adapt that lens. So so quickly, you
know, how do you find that you know making that adjustment? Yeah, and I mean the
five pages that’s like a jack shout-out Jack for just give me a assignments but
it was definitely an adjustment just with I didn’t really understand the
audience the same way. I feel like I needed to do a lot of digging. I remember
on that first day. I spent most of the day first probably two days just reading.
Mmm articles trying to understand Googling different companies. And I think
that’s right when our our agency 100 dropped so I got a good briefing just on
like the big names by reading through all those but it was definitely an
adjustment just with I think interviewing people helped. So for a couple of
those articles, like you said the ones that were just about marketing campaigns
and stuff like that. I got to talk to the people who were behind it. Which also
just helped with like Skills of you know being able to speak to somebody over,
you know Zoom can be a little awkward but I really learned a lot from those
experiences and just kind of one of the people said like it’s a very niche
market and I think that’s true but it is like you don’t realize how important it
is. So that was really cool. Right? So aside from that sort of Greater
appreciation of the industry that you got from kind of being an Insider a little
bit. Would you say like your friends, you know and people you know younger
people in their 20s or you know college age some you know, what other people in
your peer group feel about the industry and kind of like you think that there
are so kind of like that’s the extent of their knowledge is kind of what they
see on on, you know, the trending, you know, mini-series or whatever on on
Netflix or something. You know, what would you kind of tell them, you know, if
you were at a cocktail party now that you’ve gotten this, you know greater
understanding. Yeah, I think I would tell them you know, it’s more than ozempic.
It’s more than just the that was the big thing that we all knew about from
tiktok and stuff. And I think I would just tell them like it’s worth looking
into I think there’s a lot of my friends are, you know, definitely the people
who are getting all their information from tiktok they’re going on there and
they’re finding these like when I wrote I wrote like a medical misinformation
piece on tiktok and my friend was like, oh my god. I’ve been doing some of those
things. So I was like, she’s been like sleep tape like taping or face when she’s
sleeping. I was surprised but also I wasn’t I think a lot of them do have a
little bit of a almost weariness when it comes to drugs and stuff like that just
from like our exposures really dope sick and kind of stuff like that and you see
all these like horror stories on tiktok and it just kind of blossoms, but I
think I would tell them it’s worth looking into it’s a huge industry and they
are doing a lot Of good, there’s definitely some flaws but they’re really, you
know, trying to better people’s lives and ideally so are the marketers they’re
trying to really out like find the people who need help and can benefit from
these drugs. I just want to hop in there because I think Molly underscores a
really important thing and I know that in the trend segment, we’ve talked about
face taping and vampire teeth and all these sorts of things. I know that
sometimes we have a laugh about it or I’ve even heard from people like, you
know, why talk about that on the show or why give that coverage and it’s like,
okay so it might not be your cohort. It might be if you’re in the industry or if
you’re an older generation or something, but you are gen Z. It’s the first time
I’ve ever felt old in my working career is somebody that is that much younger
than me, but you come with a different media consumption a different way that
you view things and that’s been very insightful. I don’t know about you but it’s
been very insightful for me seeing like oh, this is how I consume or view the
world but there is another generation that has a whole different way and if you
don’t communicate and understand their Needs appropriately then that’s where the
disconnect and that’s where misinformation all these other sorts of History
issues can still proliferate. Yeah, and I think with that and stuff. I mean a
lot of my friends have these it’s even with like Advil and stuff. So they’ll be
like, oh, I don’t want to take too much medication or something like that. I’m
not like a pill Pusher but I’m like if you have a migraine taken Advil, but I
think there is just this mistrust and just lack of understanding. It really
comes down to just not knowing and that’s why I think it’s important to talk
about this, you know misinformation and yeah, we’re giving me a platform but
we’re giving in a bad platform, you know, we’re proving that it’s not accurate
so that when somebody because people are seeing these videos and if you just
ignore it, it’s just going to perpetuate it. So absolutely I wanted to ask you
Molly because last Mark said five pages worth of stories. I think that’s more
than most interns probably get in and you’re going back into the world with a
lot of Clips, which I’m excited about what are some of the stories that you are
the proudest of the ones that you even Enjoy the most and you’ve gone to
different Live Events too both with me Lesha on your own. You know, what stands
out from your coverage? Yeah. I think I mean I really did like that story last
week about the pommel horse guy. That was just fun just being able to kind of
freely write a little bit more because some of them each one. I feel like has a
different tone and style which was something that was huge to learn through
this. I did find by the end of it. I was really like Satisfied by some of the
financial reports for just like getting and I was like, okay, I think I got
everything it was like nice and organized or Lack of a better term. But yeah, I
think the pommel worst guy story is really fun to write. So you need just cuz I
love her big seemingly fan and then I wrote the medical and misinformation
story. It was one of my first weeks. I think it might have been my first week,
but that was just really cool to kind of tie in like my generation and talk
about tiktok. And it’s it’s plays such a big role in all like my life and in my
friends lives whether we like it or not. So it was cool to be able to kind of
like delve deeper into that and then as for events, I mean I got to go some some
really cool stuff. I got to go with Lasha to this event at her house tower which
by the way has the coolest view of Central Park from above I was looking up
there. I was like, oh my god, I’ve made it pretend it was my corner office, but
it was really really interesting. It was the mine Labs event and it’s amazing
speakers. Ashlyn Harris teffy post a tiktoker. She was really funny and it was
really cool to hear their different perspectives coming from like an athlete and
mental health and going into the Olympics. It was cool to have that background
where she had talked about how it’s like managing this pressure and handling it.
And then there’s been a lot of talk about it with you know, Simone biles and you
just see it in these people these athletes faces when they you know, accomplish
something how much it weighs on them, I guess. But then it was all really
interesting. There were a lot of magazine editors there. So like the editor of
Men’s Health Women’s Health Good Housekeeping and Oprah Magazine, we’re all
speakers and that was just really interesting to just hear more from like this
industry and kind of like get even more information and insight and one of the
interviewers was the editor of Cosmopolitan and she was like in her like 30s
like very funny and just excited to be there and it was like infectious and She
interviewed Tuffy post on that was really really just a funny light-hearted but
also deep and insightful conversation about, you know, just regular people and
their mental health. Yeah. It’s really interesting you talk about that Molly. I
think you were calling back to the dark ages of when I first joined mmm. I think
the prevailing issue then was the Ties between industry and medicine and the
fact that you know, we needed to create distance between industry and its undue
influence on the practice of medicine, you know, whether that played out and
continuing medical education and the funding of that or other areas that was
kind of like a big theme of the mid pots and now, you know fast forward more
than a decade and a half here almost two decades and it’s really influencers and
I think and you know, the power of influencers even though they’ve been around
you and they started as patient ambassadors, I guess back in 2014 or so that was
kind of the term that was used, you know disease awareness disease State
ambassadors and we saw the growth of networks, you know, like, you know health
union and those kinds of networks of health health influencers, and now with
kind of like, you know, the tiktok crowd and people kind of developing their own
brand and forging their own. Ties with with industry in some cases are just
being independent which precipitated the recent FDA guidance that we saw, you
know, replacing the 2014 guidance on how to correct misinformation. Often
arising from these independent influencers and I think the power of health of
patient influencers is really about to be Unleashed in a big way where we’re
starting to see that Studies have shown that the trust that they engender with
audiences carries over into a Pharma companies brand advertising and can really
help not only stimulate awareness, you know for products, but can result in
increased demand for products. And so I think we’re on the cusp of something
really big there and you’ve kind of hit on that, you know in your coverage. Does
that a trend that you what do you foresee happening there, you know kind of that
you since you have a kind of a good feel for those jackpot you’re in gen Z, you
know your firmly in that world that is comfortable that grow up with social
media and it’s comfortable, you know sifting through what you see on tiktok.
What do you foresee for that industry or the next 18 months? I think it’s really
interesting. How like I feel like through this job. I’ve seen a lot of how it
shifted like I knew how it was present day. A lot of people, you know, listen to
influencers and stuff but going through the maahs stuff and kind of seeing the
past how it was, you know, even how the awards changed it would be. Like it also
was more electronic like data and analytics and then it was shifting to social
media use and TV and it just it is cool to see out of all over time. I do think
there is something kind of unique with Jen gen Z just where a lot of They kind
of they’re there’s a level of straightforwardness or bluntness where people are
just willing to share pretty much everything to a false at times. But I do think
it’s a good way to you know, create these conversations and I think social media
is really where that happens. It would be interesting to just like the way that
AI plays into it all and in the future just seeing like how AI shifts this
industry and its self but like social media is just here to stay don’t and don’t
see that going anywhere. I am curious to see like what the new social media will
be because I feel like you know it Facebook is at this point for us. At least
it’s kind of like do you even have it on your phone? And then, you know a little
bit more of Twitter Instagram, but everybody’s just on tiktok and that was you
know, the last couple years so should be cool to see if another one emerges or
how that goes, right? Oh, yeah. I think I think we have some people in our
audience that would pay very good to mine your in your generation’s. Its brains
media consumption. I’m sure there are people there. They’re like, wait a second.
They’re not on Facebook anymore. Like they don’t even have another phone but
that’s for a whole different conversation. We’ve talked a lot about your
experience here with covering the industry and learning a bunch of stuff. I
wanted to focus back on to you for a second. So you’re going into your senior
year. What are you looking forward to when you go back to Ohio? Yeah. I mean
first things first. I leave a week from today. I’m really excited to see all my
friends, of course and also just I have some really great classes coming up this
semester. It’s my senior year. So I kind of like a little bit more flexibility
with what I got to pick. So I have a couple that I’m taking detective fiction
which will be really cool and film folklore and fairy tales very curious. But
yeah, so I have an exciting academic roster and then just being able to be back
with my friends and have a full year. Just kind of embracing The joy of college
one last time and you know making the most of it and really really excited. I’ve
got a house with six my best friends and we bring all of our neighbors or our
other friends. So it’s just gonna be a really great Year enjoy that it’s great.
I’m not gonna speak on behalf of Mark or fits here, but I can say only for my
own experience of living in a house with not seven. I had seven other people but
that senior year is definitely one of those times. I look back on fondly and I
wish the best for you when it comes to post-grad. So you’ve now had this
introduction to journalism and what we do, I think that journalism, you know, I
I say, this is somebody that majored in it has made a career out of it does give
you a bunch of different opportunities in terms of writing editing
Communications marketing you name it. Is there anything that you’re looking at
Postcard? I know it’s almost a year away at this point. Is there anything that
you’re looking at? You’re like, oh, maybe this is something I’d like to do or
where do you see your career path going? Yeah. I really have enjoyed. I mean, I
hadn’t thought a lot about journals until this job. Really just because I didn’t
like I I wasn’t on the student paper or anything like that. So it was really
just a lack of exposure and I’ve really enjoyed it. I’ve really enjoyed, you
know getting to write stuff. I find it very fulfilling and it’s very like I like
the deadlines and being able to kind of turn it over and get it in and I also
think it’s a great way to just stay up to date. Like I’ve I’ve been checking the
newspaper every day. But so I do see that in my I could definitely see myself
pursuing that or I love books always loved books. It would be a dream to work
and any kind of publishing or anything surrounding books and writing even just I
could see myself in the distant future after you know years of corporate America
becoming like a high school English teacher. I really would love to share that
and yeah, I’m excited though. Got a couple of good. I do ideas I guess and we’ll
see where it goes. That’s all you need at this age. And for anybody in our
audience that is connected in the publishing. Industry. Yeah, maybe this be a
recommendation from marking myself. Molly is for the taking Molly up before we
go into the trend segment. It’s been wonderful having you as an intern and we’ve
been able to see you grow and contribute to the team in a real like you said
fulfilling way. It’s really improved our coverage and I think you personally on
that for let’s say next year when we have our next Molly. If there’s somebody
that’s interested in interning at Haymarket, it’s not really just with mmm, but
like you’ve got to interact with what is it like two dozen other India. So we
have here what sort of advice would you give to them in terms of like hey, this
is what the culture is like or this is what the expectations are. What if
somebody said I’m an intern or I want to intern at Haymarket. What would you say
to them? Yeah. I mean a lot of my friends from school also have internships and
it is unique the just the you guys really accept the interns into the atmosphere
very, well. I always kind of felt like I was a part of the team which is really
impressive and a great feeling when you’re working somewhere. I would say if you
know, hey markets are really great place to enter or not. They have that great.
We touched on it earlier the internship project that goes throughout but I also
do feel like I am just being in the office being around people and a corporate
setting. I’d never done that before big change from waitressing, but it’s just
it really is a great learning opportunity. I’ve come out of this with more than
I ever. Thought I would I didn’t really know exactly what I was kind of getting
into. Yeah, I knew what Stephen told me but it’s exceeded my expectations
exponentially. Yeah, and if you do end up interning at Haymarket, I would just
say reach out to people and take in every second of it whether it be like if
you’re in mmm, or if you’re writing articles just going back to you really gonna
just showing me like what I was doing right what I was doing wrong and just kind
of trying to improve and yeah, it was really amazing. Awesome man. Well, I’m
glad that this experience did live up and exceeded those expectations. We wanted
to be able to have you you know, whether it was covering a campaign or going to
a live event or I know those fine. I’ve done those financial briefs for years
and years or not. They’re not the most fun thing to do but there is a value in
saying oh I got all the right information and you’re able to put it out there.
So again, I appreciate you being a part of the team and being game for anything.
That’s not always a given with Turns and hopefully that’s something that we
excel at here at Haymarket media trending that brings an end to our exit
interview segment here. We’ll go into our Trends and just a couple hours before
we were set to record this we were going to talk primarily about the Trump
healthcare plans that are in agenda 47, but then Kamala Harris vice president
announced a Minnesota Governor Tim. Walz as her running mate, that’s per a bunch
of news reports by the time that you’re listening to this are audience. They
will have already had their opening rally in Philadelphia walls had emerged
alongside Josh Shapiro, the governor of Pennsylvania and Arizona Senator Mark
Kelly is the finalists and ultimately he won out there’s a lot to unpack in
terms of walls Healthcare track record. There’s his defending of abortion
access, especially since he was reelected in 2022 as well as gender affirming
care his thoughts on the national covid-19 response. He’s been very Progressive
on a number of Health Care issues Supported medical research of cannabis and the
legalization of recreational cannabis in the state extended Veterans Affairs
studies on the effects of Agent Orange. He was also a member of the National
Guard and there is also some issues in terms of you know, how Progressive he’s
going to be versus what was an earlier conservative record Mark. I want to bring
you into the conversation. There’s not we have had a ton of time to really
unpack Tim. Walz as the healthcare giant, but what’s your initial read? It’s
kind of like a JD Vance situation in we have a Midwestern guy with not a ton to
give us on the healthcare side. But at least some breadcrumbs. Yes, some
breadcrumbs good way to put it to Specialty, you know in the area of
Reproductive Rights. He was called somebody who’s so pro-choice. He said that
Nancy Pelosi had asked him to tone it down. He’s kind of in the plan Parenthood
Camp. He was giving when he was in the House of Representatives from 2007 to
2019. He was giving a 0% pro-life score from the national right to life. And if
you look at his voting history there and as governor and 2023 January 2023, he
signed a measure that effectively removed all restrictions on abortions and
Republican lawmakers said that law would allow for abortions in any stage of
pregnancy. So there’s no doubt about his Bona fides when it comes to, you know,
protecting women’s Reproductive Rights. So that kind of aligns him with Kamala
Harris’s stance, which I think I would argue is the thing that we know most
about her in terms of a healthy standpoint. And I think a lot of people are
waiting to hear more details. She hasn’t really sat for any kind of substance of
interview in the last two weeks since she became the presumptive Democratic
nominee. Yeah, and another thing just to add to Tim. Walz is Healthcare track
record is that he did vote in favor of Medicare drug price negotiations when he
was in the House of Representatives. So obviously that’s something that’s come
to the four just bring in the other side of things too. There’s been a lot of
speculation talk in the media about project 2025 and whether or not that would
be kind of this conservative wish list for policies. If former president Trump
is elected back to the White House. He is he in the campaign of distance himself
from that and they’ve put out agenda 47 which is kind of their own wish list in
terms of this is what we’re going to do the USA Today did a great breakdown will
link to it in the show notes here, but they just did a rundown of like here the
things that are actually important in healthcare wise especially for for our
audience to say the farmer Community. There is the promise to bring back
pharmaceutical production to the US that was something that is listed in agenda
47. There’s also getting tougher on Farmers Google companies Market, I think. I
talked about this. It’s not last week’s episode the one before where I don’t
think Farmers really gonna find much of an ally whether or not you get a Harris
or Trump a second Trump Administration. It seems like they’re going to be faced
between a rock and a hard place. There will be interesting to see how they Lobby
on that and then there was talk from Trump about eradicating the drug addiction
crisis in America. I know that’s something that the Harris campaign is also
focused on too with different approaches. I think there’s a more aggressive
line. You would say from the Trump Administration. There’s talk of cracking down
on drug cartels imposing the death penalty on drug dealers threatening China
with exporting fentanyl like there. There’s a lot more there. That’s more I
would say Aggressive but it gives us a glimpse too. And to now that we have
these four people Trump advance and then Harrison walls. This is kind of where
the the healthcare industry has to make their bones policy wise, right? Yeah the
sort of know that they’re up against either Administration would not be allies,
you know, in terms of the drug pricing agenda. I think they would keep up the
pressure. You know, some people may recall that Kamala Harris was the deciding
vote in Congress, you know, when the IRA was up for a vote and it was a split
50/50. She was the decisive vote that got that through and that’s one of the
Biden policy achievements that she is, you know taking credit for to what extent
you know, she was involved. We don’t know but she will, you know sort of count
that among her Bonafide he’s moving forward and she giving her, you know,
everything we know about her agenda. She will probably, you know continue to
push. There and Trump, you know, when he was in office, you know, he was famous
for saying that, you know, the drug companies are quote unquote killing people,
you know with their high prices, but he was not able to you know, effectively,
you know, push through much, you know, as effective as the IRA was and kind of
introducing drug price negotiation. I think what we’ll need to keep an eye on
you know is and this is more of a concern with a Kamala Harris president see is
you know, and I think the farm industry really fears this from an existential
point of view, whether they’re going to use the IRA to kind of really expand,
you know, as a platform, you know to to expand the reach of drug price
negotiation beyond the remit that it currently is called for in the current
legislation. I think nobody, you know, people really want to stem stem the
bleeding from that so to speak I don’t know if the fear is so is quite as acute,
you know with a trump president is it would be you know from a Harris one? Yeah.
It’s interesting you bring that up too because we’ve been obviously Molly and
I’ve been following these quarterly. Ranks reports and there have been a number
of companies the ones that are more front-facing with the IRA saying like, oh we
expect to have this sort of damage or we’ve gotten the Final prices, but they
expect a limit it so it’s it’s interesting kind of the talking out of both sides
of your mouth where it’s like, oh no, we expect this to be really harmful to our
bottom line by the same time. They’ve already calculated how much that’s really
gonna hamper them from a financial perspective. So that’s interesting one other
note. I’m going to make just in terms of the healthcare record. I don’t think
that we’re going to see another HHS secretary if Trump gets elected who used to
work for Eli Lilly. I think those days are probably gone just from the messaging
and the and the Optics that we’ve seen there and one final thing too. I said
earlier that the healthcare industry is faced with two choices between Harrison
and Trump. I don’t want to overlook the fact that yes RFK Jr. Is still in the
race. We didn’t have enough time in this week’s pod to talk about hiding a dead
bear cub in Central Park. So my apologies there for anybody who was missing that
I want to move on to our last story here, which is the Wall Street Journal has
had a deeper dive into the light Coast Therapeutics MDMA trial Mark curious your
thoughts. This is a pretty expansive rundown. We don’t have to give you know,
the highlights to our audience will link to it in the show notes by hasn’t read
it already but it’s just another lump on like ghosts and it seems troubling if
nothing else in terms of how they’ve how this reporting has gone about this.
Yeah, another lump on lycos well said, you know basically back in June 5th. We
saw the results of the advisory committee meeting for lycos Therapeutics MDMA
assisted therapy and was more negative than expected. Even with unfavorable
voting results The Briefing documents that had been released May 31st kind of
telegraph that but some of the problems there that they were focusing on was the
functional unblinding and expectation bias durability of effects of
psychotherapy the risk assessment as well as a proposed Rems program and you
know to put it I think mildly, you know, it’s unlikely that the light goes MDMA
assisted therapy is going to be approved on August 11th, which was the Paducah
data originally set for that. And this was for treating PTSD it PTSD, excuse me,
and the lot of these concerns had been surfaced. Is a report and as I mentioned
the FDA briefing documents, so I think the street, you know, in terms of, you
know, a read through just to other companies in the Psychedelic space. There’s
other companies that are pursuing PTSD therapies with you know, MDMA and people
are saying that the read through is limited, you know, and and that the, you
know, the psychedelics space still has potential, you know, great potential
despite the shortcomings here and I encourage readers to delve into the wsj deep
dive themselves, but it gives a good obviously, you know, they took the I think
what came out of the briefing documents and they Did some interviews with some
of the trial subjects and there was some really serious impropriety going on
there between the subjects and one of the therapists, you know lycos to their
you know for their part, you know has has denied that there was you know and
proprieties going on here. But and then they stand behind the data but you know,
the street is not looking favorably toward this August 11th Paducah date. But
again the read through to the Psychedelic space in general is limited. Yeah,
it’s one of those things too where you know what this means just like that was
going forward. I think a lot of people are gonna be watching what happens in the
next week with great interest. I would just say this that you know, we cover a
lot of different trials that you know, don’t meet their expectation or their
side effects and companies have to Wrangle with that. There is something that’s
a little bit different when it’s dealing with subject of mental health and
suicide and I think that’s kind of what elevates it too. Like the fact that the
Wall Street Journal here has Interviews with trial subjects who are saying the
treatments brought back memories of traumatic events in their life. And this is
supposed to be a treatment that’s supposed to remedy that or mitigate that
damage is something that is very troubling I think for anybody that’s involved
whether you’re in the industry or watching from afar so definitely something
will follow with with interest going forward, but it’s it’s certainly topping
news and our industry. So it’s worth delving into a little bit there. Like I
said, well include a link in the show notes in case anyone hasn’t read it but I
think with that we’re good Molly. Thank you for thank you guys for having your
insights. Do you want to read I know we usually throw this to Mark to say thank
you, but you want to get us on that last one of a preview for the podcast next
week. Sure. Thanks for joining us on this week’s episode of the mmm podcast. Be
sure to listen to next week’s episode when we joined by Raja Haddad Chief
marketing officer at Primo. Oh, that’s it for this week. The mmm podcast is
produced by Bill Fitzpatrick Gordon. Our theme music is by Susie himself rate
review and follow every episode wherever you listen to podcasts new episodes
every week and be sure to check out our website and then hyphen online.com for
the top news stories and farmer marketing.
TOPICS:
MMM Newsletter PM The MM+M Podcast MMM Newsletter Weekender Podcasts MMM
Newsletter Weekly Digest Top Stories 6 People Podcast
* AI DECIPHERED: DISCOVERING THE POTENTIAL FOR MARKETERS AND COMMUNICATORS
The daylong conference is specifically designed to answer the multitude of
questions communicators face as they figure out how to use this powerful new
tool to their advantage.
FROM OUR PARTNERS
slide 1 to 4 of 4
PARTNER CONTENT
CONTEXT IS THE NEW CURRENCY
The digital marketing landscape is changing but the challenge for marketers
remains: how to develop campaigns that deliver relevant, actionable content to
hyper-targeted audience profiles.
PARTNER CONTENT
HOW AI AND FIRST-PARTY DATA IS TRANSFORMING PHARMA CUSTOMER ENGAGEMENT
Using technology to improve audience segmentation, targeting and virtual
interaction.
PARTNER CONTENT
THE IMPORTANCE OF FEMALE REPRESENTATION IN HEALTH
How to effect change and close the gender gap in healthcare.
PARTNER CONTENT
THE A100 PLAYBOOK PODCAST | REAL CHEMISTRY: VISUALIZING THE FUTURE: ART, SCIENCE
AND AI INNOVATION
Listen to Jack O’Brien of MM+M and Brandon Pletsch, president of scientific
visualization at Real Chemistry, as they delve into the dynamic intersection of
art, science and AI innovation in the field of scientific visualization.
Get the most out of
Register for free and enjoy unlimited access to:
* News
* Agency 100 Content
* Podcasts
* Awards Content
* And More
{{login-button}}
{{register-button}}
*
*
*
*
*
*
* * News
* Subscribe
* About Us
* Contact Us
* Advertise
*
* Copyright © 2024 Haymarket Media, Inc. All Rights Reserved This material may
not be published, broadcast, rewritten or redistributed in any form without
prior authorization. Your use of this website constitutes acceptance of
Haymarket Media’s Privacy Policy and Terms & Conditions.
* Your Privacy Choices
Close more info about MM+M summer intern Molly Huth, ‘a natural behind the mic,’
says goodbye
LOG IN TO YOUR ACCOUNT
NEED A MM+M ACCOUNT? CREATE ONE.
Keep me signed in
Log in
Forgot your password?
Close more info about MM+M summer intern Molly Huth, ‘a natural behind the mic,’
says goodbye
CREATE A MM+M ACCOUNT
Already have an account? Log in.
THANK YOU FOR CHOOSING MMM-ONLINE.COM. SIGN UP FOR YOUR FREE ACCOUNT NOW AND
JOIN THE THOUSANDS OF HEALTHCARE MARKETING PROFESSIONALS WHO RELY ON US FOR ALL
THE LATEST INDUSTRY NEWS, ANALYSIS AND TRENDS. YOU'LL BE ARMED WITH THE TOOLS
YOU NEED TO MAKE KEY DECISIONS IN THIS DYNAMIC MARKET AND EXCEL IN YOUR ROLE
EVERY DAY. SIMPLY COMPLETE THE BRIEF FORM BELOW.
Job Title*Corporate Management (C-level, President, etc.)Marketing/Advertising
ExecutiveProduct/Brand/Therapeutic Executive (SVP, VP, Director, Manager,
etc.)MediaCreative/DesignPublic Relations/CommunicationsSales ManagementMarket
ResearchCMEMedical DirectorMedical/Scientific AffairsManaged CareR&DRegulatory
AffairsTechnologyFinanceOperationsConsultingEducator/Student/InternOther
Title Level*C-LevelVP/SVP/EVPDirectorManagerNon-ManagerOther
Industry*Healthcare Manufacturer - OtherHealthcare Manufacturer -
PharmaceuticalHealthcare Manufacturer - BiotechnologyHealthcare Manufacturer -
Device/DiagnosticsAdvertising/Marketing/CommunicationsMedia
CompanyCreative/Design FirmMarket Research FirmAccredited
CME/EducationHealthcare Consulting Company (does not incl. independent
consultants)TechnologyPayor/PBM/InsurerHospital/Health System/Medical
CareNon-Profit/Association/Government AgencyRetail/Wholesale/DistributorPrivate
Equity/Finance/InvestorBusiness ServicesIndependent Consultant/FreelancerOther
*CountryUnited States
SIGN UP FOR OUR EMAIL UPDATES.
The Splash from MM+M
MM+M Weekly Digest
MM+M AM, PM and Weekender
I would like to receive relevant information via email from MM+M.
Register
Sign in now.
By registering you consent to the collection and use of your information to
provide the products and services you have requested from us and as described in
our privacy policy and terms and conditions.
MANAGE CONSENT PREFERENCES
This website uses cookies and similar electronic technologies to enhance your
experience, provide you with relevant advertising, and to analyze performance
and traffic on our website. We also share information about your use of our site
with our social media, advertising and analytics partners. Certain cookies, such
as our first party cookies, are essential and necessary to the functionality of
the website and cannot be opted out of. You may also view our Privacy Policy for
additional information. The California Consumer Privacy Act (CCPA) gives
consumers the right to opt-out of “sales” and “shares” of personal information.
Other U.S. state privacy laws (e.g., Colorado) give consumers the right to
opt-out of “sales” of personal information and processing of personal
information for “targeted advertising” purposes. Please use the mechanism below
to effectuate these rights. To Opt out, slide the toggle to the left.
Alternatively, customers residing in certain US States may exercise their data
privacy related rights outlined in our Privacy Policy (See section - State
Specific Privacy Rights).
More information
Accept
STRICTLY NECESSARY COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work. These cookies do not store any personally identifiable information.
* FUNCTIONAL COOKIES
Always Active
These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies
then some or all of these services may not function properly.
DO NOT SELL OR SHARE PERSONAL INFORMATION
Do Not Sell or Share Personal Information
* PERFORMANCE COOKIES
Switch Label label
These cookies allow us to count visits and traffic sources so we can measure
and improve the performance of our site. They help us to know which pages are
the most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If
you do not allow these cookies we will not know when you have visited our
site, and will not be able to monitor its performance.
* TARGETING COOKIES
Switch Label label
These cookies may be set through our site by our advertising partners. They
may be used by those companies to build a profile of your interests and show
you relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.
Back Button
PERFORMANCE COOKIES
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
Switch Label label
Switch Label label
Switch Label label
Confirm My Choices